Literature DB >> 10421483

Alteromonas prolidase for organophosphorus G-agent decontamination.

T C Cheng1, J J DeFrank, V K Rastogi.   

Abstract

Enzymes catalyzing the hydrolysis of highly toxic organophosphorus compounds (OPs) are classified as organophosphorus acid anhydrolases (OPAA; EC 3.1.8.2). Recently, the genes encoding OPAA from two species of Alteromonas were cloned and sequenced. Sequence and biochemical analyses of the cloned genes and enzymes have established Alteromonas OPAAs to be prolidases (E.C. 3.4.13.9), a type of dipeptidase hydrolyzing dipeptides with a prolyl residue in the carboxyl-terminal position (X-Pro). Alteromonas prolidases hydrolyze a broad range of G-type chemical warfare (CW) nerve agents. Efforts to over-produce a prolidase from A. sp.JD6.5 with the goal of developing strategies for long-term storage and decontamination have been successfully achieved. Large-scale production of this G-agent degrading enzyme is now feasible with the availability of an over-producing recombinant cell line. Use of this enzyme for development of a safe and non-corrosive decontamination system is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421483     DOI: 10.1016/s0009-2797(99)00058-7

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  12 in total

1.  In vitro release of organophosphorus acid anhydrolase from functionalized mesoporous silica against nerve agents.

Authors:  Baowei Chen; Saumil S Shah; Yongsoon Shin; Chenghong Lei; Jun Liu
Journal:  Anal Biochem       Date:  2011-10-02       Impact factor: 3.365

2.  Novel mutation in Cul7 gene in a family diagnosed with 3M syndrome.

Authors:  Shagufta Shaikh; Suresh K G Shettigar; Santosh Kumar; Surita Kantharia; Jagannath Kurva; Susan Cherian
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

3.  Crystallization and preliminary X-ray diffraction analysis of the organophosphorus hydrolase OPHC2 from Pseudomonas pseudoalcaligenes.

Authors:  Guillaume Gotthard; Julien Hiblot; Daniel Gonzalez; Eric Chabrière; Mikael Elias
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-12-25

Review 4.  Organophosphorus-degrading bacteria: ecology and industrial applications.

Authors:  Brajesh K Singh
Journal:  Nat Rev Microbiol       Date:  2008-12-22       Impact factor: 60.633

5.  Multiple mechanisms contribute to lateral transfer of an organophosphate degradation (opd) island in Sphingobium fuliginis ATCC 27551.

Authors:  Emmanuel Vijay Paul Pandeeti; Toshisangba Longkumer; Deviprasanna Chakka; Venkateswar Reddy Muthyala; Sunil Parthasarathy; Anil Kumar Madugundu; Sujana Ghanta; Srikanth Reddy Medipally; Surat Chameli Pantula; Harshita Yekkala; Dayananda Siddavattam
Journal:  G3 (Bethesda)       Date:  2012-12-01       Impact factor: 3.154

6.  Improving the catalytic activity of hyperthermophilic Pyrococcus horikoshii prolidase for detoxification of organophosphorus nerve agents over a broad range of temperatures.

Authors:  Casey M Theriot; Rebecca L Semcer; Saumil S Shah; Amy M Grunden
Journal:  Archaea       Date:  2011-11-28       Impact factor: 3.273

7.  Catalytic bioscavengers against toxic esters, an alternative approach for prophylaxis and treatments of poisonings.

Authors:  Patrick Masson; Daniel Rochu
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

8.  Aminoalcohol-Induced Activation of Organophosphorus Hydrolase (OPH) towards Diisopropylfluorophosphate (DFP).

Authors:  Dandan Li; Yunze Zhang; Haitao Song; Liangqiu Lu; Deli Liu; Yongze Yuan
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

9.  Advances in toxicology and medical treatment of chemical warfare nerve agents.

Authors:  Mohammd Moshiri; Emadodin Darchini-Maragheh; Mahdi Balali-Mood
Journal:  Daru       Date:  2012-11-28       Impact factor: 3.117

10.  Structural and enzymatic characterization of the phosphotriesterase OPHC2 from Pseudomonas pseudoalcaligenes.

Authors:  Guillaume Gotthard; Julien Hiblot; Daniel Gonzalez; Mikael Elias; Eric Chabriere
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.